| Literature DB >> 29758072 |
Lixia Ge1, Chun Wei Yap1, Bee Hoon Heng1.
Abstract
OBJECTIVES: The aims of the study were to identify the associations between multimorbidity and specific physical function domains among community-dwelling adults in Singapore, and to examine sex differences in the associations.Entities:
Mesh:
Year: 2018 PMID: 29758072 PMCID: PMC5951575 DOI: 10.1371/journal.pone.0197443
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the study population.
| Variable | Total, n (%) | Men, n (%) | Women, n (%) | |
|---|---|---|---|---|
| 51.4±17.3 | 52.0±17.5 | 50.9±17.1 | 0.17 | |
| 21–44 | 647 (36.7) | 273 (35.0) | 374 (38.0) | |
| 45–64 | 776 (38.9) | 354 (38.7) | 422 (39.1) | |
| ≥ 65 | 517 (24.4) | 232 (26.3) | 285 (22.9) | |
| 0.74 | ||||
| Chinese | 1522 (78.3) | 671 (77.8) | 851 (78.7) | |
| Malay | 154 (8.2) | 68 (8.3) | 86 (8.2) | |
| Indian | 209 (10.9) | 99 (11.6) | 110 (10.4) | |
| Others | 55 (2.5) | 21 (2.2) | 34 (2.8) | |
| No formal education | 258 (12.6) | 93 (9.9) | 165 (14.8) | |
| Primary | 251 (12.5) | 115 (12.8) | 136 (12.3) | |
| Secondary (sec) | 600 (29.4) | 261 (29.7) | 339 (29.2) | |
| Post sec & above | 831 (45.4) | 390 (47.6) | 441 (43.7) | |
| Never smoked | 1444 (76.2) | 452 (54.9) | 992 (92.8) | |
| Current smoker | 258 (12.4) | 212 (23.1) | 46 (4.0) | |
| Former smoker | 238 (11.4) | 195 (22.0) | 43 (3.1) | |
| Never | 845 (42.1) | 315 (34.5) | 530 (48.0) | |
| Almost never | 139 (7.2) | 63 (7.2) | 76 (7.3) | |
| Once in a while | 388 (19.9) | 159 (18.1) | 229 (21.2) | |
| Often | 396 (20.9) | 210 (25.3) | 186 (17.5) | |
| Very often | 172 (10) | 112 (14.9) | 60 (6.1) | |
| Never | 569 (28.7) | 235 (26.0) | 334 (30.8) | |
| Almost never | 159 (7.5) | 56 (5.9) | 103 (8.8) | |
| Once in a while | 360 (18.4) | 145 (16.5) | 215 (19.8) | |
| Often | 518 (27.0) | 244 (28.9) | 274 (25.5) | |
| Very often | 334 (18.4) | 179 (22.7) | 155 (15.0) |
Note: Numbers in parentheses are weighted column %.
Sex- and age-specific prevalence of chronic diseases and multimorbidity, n (%).
| Chronic condition | TOTAL (N = 1,940) | Men (n = 859) | Women (n = 1,081) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 21–44 | 45–64 | ≥ 65 | Total | 21–44 | 45–64 | ≥ 65 | Total | |||
| 711 (35.7) | 28 (10.3) | 144 (40.7) | 166 (71.6) | 338 (38.4) | 20 (5.3) | 160 (40.4) | 193 (68.3) | 373 (33.5) | ||
| 625 (30.4) | 26 (9.5) | 125 (35.3) | 160 (69.0) | 311 (34.9) | 11 (1.7) | 108 (26.3) | 195 (69.5) | 314 (26.9) | ||
| 317 (16.3) | 13 (4.8) | 58 (16.4) | 80 (34.5) | 151 (18.1) | 19 (4.3) | 66 (16.9) | 81 (29.3) | 166 (15.0) | ||
| 329 (15.5) | 11 (4.0) | 53 (15.0) | 74 (31.9) | 138 (14.6) | 15 (3.1) | 72 (16.7) | 104 (36.9) | 191 (16.3) | ||
| 133 (7.1) | 24 (8.8) | 14 (4.0) | 14 (6.0) | 52 (6.0) | 41 (11.4) | 30 (7.3) | 10 (4.0) | 81 (8.0) | ||
| 109 (5.5) | 0 (0) | 11 (3.1) | 46 (19.8) | 57 (6.6) | 2 (0.2) | 12 (2.8) | 38 (14.5) | 52 (4.6) | ||
| 115 (5.1) | 0 (0) | 8 (2.3) | 20 (8.6) | 28 (2.5) | 3 (0.7) | 28 (6.3) | 56 (19.3) | 87 (7.2) | ||
| 94 (4.7) | 0 (0) | 23 (6.5) | 39 (16.8) | 62 (7.2) | 0 (0) | 5 (1.4) | 27 (9.6) | 32 (2.8) | ||
| 90 (4.2) | 0 (0) | 10 (2.8) | 33 (14.2) | 43 (4.8) | 0 (0) | 17 (4.5) | 30 (8.5) | 47 (3.7) | ||
| 85 (4.1) | 0 (0) | 10 (2.8) | 27 (11.6) | 37 (4.0) | 1 (0) | 22 (5.6) | 25 (8.5) | 48 (4.2) | ||
| 69 (3.3) | 6 (2.2) | 9 (2.5) | 5 (2.2) | 20 (2.1) | 12 (2.7) | 23 (4.9) | 14 (5.2) | 49 (4.2) | ||
| 51 (2.6) | 0 (0) | 10 (2.8) | 21 (9.1) | 31 (3.8) | 0 (0) | 6 (1.4) | 14 (5.2) | 20 (1.7) | ||
| 50 (2.4) | 7 (2.6) | 8 (2.3) | 6 (2.6) | 21 (2.5) | 2 (0.2) | 16 (3.1) | 11 (4.4) | 29 (2.3) | ||
| 32 (1.5) | 1 (0.4) | 6 (1.7) | 15 (6.5) | 22 (2.5) | 2 (0.2) | 2 (0.7) | 6 (2.0) | 10 (0.8) | ||
| 19 (1.0) | 3 (1.1) | 3 (0.8) | 1 (0.4) | 7 (0.7) | 1 (0.5) | 4 (0.9) | 7 (2.8) | 12 (1.2) | ||
| 19 (1.0) | 0 (0) | 1 (0.3) | 6 (2.6) | 7 (0.9) | 0 (0) | 2 (0.5) | 10 (3.6) | 12 (1.0) | ||
| 9 (0.4) | 0 (0) | 1 (0.3) | 5 (2.2) | 6 (0.6) | 0 (0) | 1 (0.5) | 2 (0.8) | 3 (0.3) | ||
| 0 | 835 (44.6) | 191 (70.0) | 135 (38.1) | 26 (11.2) | 352 (42.1) | 285 (77.3) | 160 (36.8) | 38 (12.4) | 483 (46.6) | |
| 1 | 390 (20.4) | 60 (22.0) | 93 (26.3) | 28 (12.1) | 181 (21.3) | 62 (16.6) | 108 (26.2) | 39 (13.3) | 209 (19.7) | |
| Multimorbidity (2+) | 715 (35.0) | 22 (8.1) | 126 (35.6) | 178 (76.7) | 326 (36.7) | 27 (6.0) | 154 (36.9) | 208 (74.3) | 389 (33.7) | |
Physical function domain scores (mean ± SD) by sex and age group.
| Physical function domain | TOTAL (N = 1,940) | Men (n = 859) | Women (n = 1,081) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 21–44 | 45–64 | ≥ 65 | Total | 21–44 | 45–64 | ≥ 65 | Total | |||
| UEF | 84.7±17.8 | 99.8±2.1 | 98.5±7.1 | 90.8±18.4 | 96.9±11.1 | 98.4±8.8 | 96.8±9.3 | 87.7±17.4 | 95.3±12.2 | |
| BLEF | 96.0±11.8 | 99.6±2.7 | 96.7±10.0 | 82.8±23.5 | 94.1±15.2 | 98.3±9.1 | 93.5±13.1 | 77.7±21.2 | 91.7±16.2 | |
| ALEF | 92.7±15.9 | 96.1±9.2 | 87.8±16.7 | 62.6±27.8 | 84.1±22.8 | 93.0±14.3 | 78.6±19.2 | 53.7±24.5 | 78.4±24.0 | |
| Overall | 80.9±23.7 | 96.7±7.4 | 89.9±13.3 | 71.3±20.4 | 87.4±17.3 | 93.7±12.3 | 82.4±14.8 | 64.6±15.8 | 82.6±17.9 | |
Note: UEF = upper extremity function; BLEF = basic lower extremity function; ALEF = advanced lower extremity function. P<0.05 for all Independent-sample t-tests for UEF, BLEF, ALEF and overall function between men and women in every age group, except for UEF between men and women aged ≥65 years.
Fig 1Sex differences in physical function domains by number of chronic diseases.
Associations between multimorbidity and physical function domains using multiple linear regressions.
| Variables | UEF | BLEF | ALEF | Overall function | ||||
|---|---|---|---|---|---|---|---|---|
| B | SE | B | SE | B | SE | B | SE | |
| 1 | -0.05 | 0.67 | -0.98 | 0.83 | -3.54 | 1.11 | -2.87 | 0.82 |
| 2+ | -4.27 | 0.66 | -8.79 | 0.82 | -14.27 | 1.09 | -10.95 | 0.81 |
| 45–64 | 0.41 | 0.67 | 0.005 | 0.83 | -3.70 | 1.10 | -3.12 | 0.82 |
| ≥ 65 | -4.73 | 0.90 | -8.74 | 1.11 | -18.91 | 1.49 | -13.95 | 1.10 |
| -1.67 | 0.56 | -2.73 | 0.69 | -6.62 | 0.92 | -5.35 | 0.68 | |
| Malay | -1.35 | 0.92 | -4.12 | 1.14 | -6.76 | 1.52 | -5.15 | 1.12 |
| Indian | -0.44 | 0.80 | -2.52 | 0.98 | -4.02 | 1.31 | -2.68 | 0.97 |
| Others | -3.27 | 1.48 | -3.64 | 1.83 | -6.08 | 2.44 | -4.69 | 1.80 |
| Primary | 4.35 | 0.97 | 5.32 | 1.20 | 7.59 | 1.60 | 4.97 | 1.18 |
| Secondary | 5.41 | 0.85 | 8.93 | 1.05 | 12.40 | 1.41 | 8.68 | 1.04 |
| Post-secondary | 5.65 | 0.95 | 9.25 | 1.17 | 15.93 | 1.56 | 11.45 | 1.15 |
| Never smoked | 1.41 | 0.80 | 1.25 | 0.99 | 0.44 | 1.32 | 0.62 | 0.98 |
| Former smoker | -1.49 | 0.81 | -2.35 | 1.00 | -2.59 | 1.33 | -1.41 | 0.98 |
Note: UEF = upper extremity function; BLEF = basic lower extremity function; ALEF = advanced lower extremity function, B = regression coefficient, SE = standard error
*p<0.05.
Sex differences in associations between multimorbidity and physical function domains using multiple linear regressions.
| Variables | Men | Women | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UEF | BLEF | ALEF | Overall function | UEF | BLEF | ALEF | Overall function | ||||||||||
| B | SE | B | SE | B | SE | B | SE | B | SE | B | SE | B | SE | B | SE | ||
| 1 | 0.16 | 0.95 | 0.25 | 1.23 | -1.91 | 1.67 | -1.82 | 1.25 | -0.36 | 0.95 | -2.05 | 1.13 | -4.68 | 1.49 | -3.61 | 1.09 | |
| 2+ | -4.08 | 0.94 | -6.69 | 1.23 | -11.72 | 1.66 | -9.36 | 1.25 | -4.42 | 0.92 | -10.40 | 1.10 | -16.07 | 1.45 | -12.07 | 1.06 | |
| 45–64 | 0.07 | 0.93 | -0.24 | 1.20 | -2.62 | 1.63 | -2.44 | 1.22 | 0.88 | 0.98 | 0.17 | 1.16 | -4.57 | 1.54 | -3.62 | 1.12 | |
| ≥ 65 | -4.94 | 1.25 | -9.67 | 1.63 | -20.00 | 2.21 | -14.96 | 1.66 | -4.16 | 1.30 | -7.85 | 1.54 | -18.03 | 2.04 | -13.09 | 1.50 | |
| Malay | -4.92 | 1.33 | -6.41 | 1.73 | -6.47 | 2.34 | -5.11 | 1.76 | 1.26 | 1.27 | -2.37 | 1.52 | -6.87 | 2.01 | -5.02 | 1.47 | |
| Indian | -0.98 | 1.11 | -2.74 | 1.44 | -4.04 | 1.94 | -2.95 | 1.46 | 0.02 | 1.13 | -2.43 | 1.35 | -4.15 | 1.78 | -2.51 | 1.30 | |
| Others | -3.40 | 2.27 | -2.91 | 2.95 | -7.28 | 4.00 | -5.20 | 3.00 | -2.87 | 1.96 | -3.92 | 2.33 | -5.49 | 3.08 | -4.51 | 2.25 | |
| Primary | 2.27 | 1.44 | 1.88 | 1.87 | 3.40 | 2.53 | 2.27 | 1.90 | 5.68 | 1.31 | 7.45 | 1.56 | 10.39 | 2.07 | 6.76 | 1.51 | |
| Secondary | 3.00 | 1.27 | 5.23 | 1.65 | 8.95 | 2.23 | 6.55 | 1.67 | 11.13 | 1.39 | 11.08 | 1.39 | 14.56 | 1.84 | 10.06 | 1.35 | |
| Post-secondary | 2.59 | 1.38 | 4.96 | 1.79 | 11.40 | 2.42 | 8.46 | 1.82 | 11.85 | 1.57 | 11.99 | 1.56 | 18.64 | 2.07 | 13.29 | 1.52 | |
| Current smoker | 1.64 | 0.91 | 1.63 | 1.18 | 0.13 | 1.60 | 0.19 | 1.20 | -1.79 | 2.03 | 11.08 | 1.39 | -2.40 | 2.69 | -0.28 | 1.97 | |
| Former smoker | -2.26 | 0.91 | -3.06 | 1.18 | -3.62 | 1.60 | -1.93 | 1.20 | -1.47 | 2.07 | 11.99 | 1.56 | -1.34 | 2.74 | -1.28 | 2.01 | |
Note: UEF = upper extremity function; BLEF = basic lower extremity function; ALEF = advanced lower extremity function, B = regression coefficient, SE = standard error
*p<0.05.